NCL  
Nanotechnology Characterization Laboratory Skip Navigation
 

Scientific Bibliography

A Scientific Bibliography with topics and abstracts related to nanotechnology is featured on the NCI Alliance for Nanotechnology in Cancer website.

Select NCL publications are listed here:

Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models.
Adiseshaiah, P.P., Clogston, J.D., McLeland, C.B., Rodriguez, J., Potter, A.M., Neun, B.W., Skoczen, S.L., Shanmugavelandy, S.S., Kester, M., Stern, S.T., and McNeil, S.E.,
Cancer Letters 2013, E-pub ahead of print. 
PMID: 23664889

Prediction of nanoparticle prodrug metabolism by pharmacokinetic modeling of biliary excretion.
Stern, S.T., Zou, P., Skoczen, S., Xie, S., Liboiron, B., Harasym, T., Tardi, P., Mayer, L.D., and McNeil, S.E.,
Journal of Controlled Release, 2013, E-pub ahead of print. 
PMID: 23664969

Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.
Zou, P., Helson, L., Maitra, A., Stern, S.T., and McNeil, S.E.,
Molecular Pharmaceutics, 2013, 10(5), 1977-1987. 
PMID: 23534919

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
Ilinskaya, A.N. and Dobrovolskaia, M.A.,
Nanomedicine (Lond), 2013, 8(5), 773-784.
PMID: 23656264

Handbook of Immunological Properties of Engineered Nanomaterials.
Frontiers in Nanobiomedical Research: World Scientific Publishing; 2011, Dobrovolskaia, M.A. and McNeil, S.E., eds.
ISBN: 978-981-4390-25-5

Biotargeted nanomedicines for cancer: six tenets before you begin.
Goldberg, M.S., Hook, S.S., Wang, A.Z., Bulte, J.W., Patri, A.K., Uckun, F.M., Cryns, V.L., Hanes, J., Akin, D., Hall, J.B., Gharkholo, N., and Mumper, R.J.,
Nanomedicine (Lond), 2013, 8(2), 299-308.
PMID: 23394158

Morphological development of cellulose fibrils of a bleached eucalyptus pulp by mechanical fibrillation.
Wang, Q. Q.; Zhu, J. Y.; Gleisner, R.; Kuster, T. A.; Baxa, U.; and McNeil, S. E.
Cellulose, 2012, 19(5), 1631-1643. 
DOI: 10.1007/s10570-012-9745-x

Approaching zero cellulose loss in cellulose nanocrystal (CNC) production: recovery and characterization of cellulosic solid residues (CSR) and CNC.
Wang, Q.; Zhu, J.; Reiner, R.; Verrill, S.; Baxa, U.; and McNeil, S.
Cellulose, 2012, 19(6), 2033-2047. 
DOI: 10.1007/s10570-012-9765-6

Challenges and opportunities in the advancement of nanomedicines.
Wei, A., Mehtala, J. G., and Patri, A. K.
Journal of Controlled Release, 2012, 164(2), 236-246.
PMID: 23064314

Nanotechnology in Cancer Medicine.
Grossman, J. H. and McNeil, S. E.
Physics Today, 2012, 65(8), 38-42. 
DOI: 10.1063/PT.3.1678

Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.
Crist, R. M.; Grossman, J. H.; Patri, A. K.; Stern, S. T., Dobrovolskaia, M. A., Adiseshaiah, P. P., Clogston, J. D.; McNeil, S. E.
Integrative Biology (Camb). 2013, 5(1), 66-73.
PMID: 22772974

Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity.
Stern, S. T., Adiseshaiah, P. P., Crist, R. M.
Particle and Fibre Toxicology 2012, 9:20.
PMID: 22697169

Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.
Dobrovolskaia, M. A.; Patri, A. K., Simak, J., Hall, J. B., Semberova, J.; De Paoli Lacerda, S. H.; McNeil, S. E.
Molecular Pharmaceutics 2012, 9(3), 382-393.
PMID: 22026635.

Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.
Dobrovolskaia, M. A.; Patri, A. K.; Potter, T. M.; Rodriguez, J. C.; Hall, J. B.; McNeil, S. E.
Nanomedicine (Lond). 2012, 7(2), 245-256.
PMID: 21957862.

Sterilization of silver nanoparticles using standard gamma irradiation procedure affects particle integrity and biocompatibility.
Zheng, J.; Clogston, J. D.; Patri, A. K.; Dobrovolskaia, M. A.; McNeil, S. E.
Journal of Nanomedicine and Nanotechnology, November 2011 [Epub ahead of print].
DOI: 10.4172/2157-7439.S5-001

Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine.
Afonin ,K. A.; Grabow, W. W.; Walker, F. M.; Bindewald, E.; Dobrovolskaia, M. A.; Shapiro, B. A.; Jaeger, L.
Nature Protocols, 2011, 6(12), 2022-2034.
PMID: 22134126.

Preclinical efficacy and toxicity testing of engineered nanomaterials in Nanomedicine – Basic and Clinical Applications in Diagnostics and Therapy.
Grossman, J. H.; McNeil, S. E.
Else Kroner-Fresenius Symposia, Karger Press; 2011, vol. 2, p71-79, Christoph Alexiou, editor. 
ISBN: 978-3-8055-9818-7.

Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro.
Franca, A.; Aggarwal, P.; Barsov, E.; Kozlov, S.; Dobrovolskaia, M. A.; Gonzalez-Fernandez, A.
Nanomedicine (Lond.), 2011, 6(7), 1175-1188.
PMID: 21675859.

Newkome-type dendron stabilized gold nanoparticles: Synthesis, reactivity, and stability.
Cho, T. J.; Zangmeister, R. A.; Maccuspie, R. I.; Patri, A. K.; Hackley, V. A.
Chemistry of Materials, 2011, 23(10), 2665-2676.
PMID: 21686078.

Interlaboratory comparison of size and surface charge measurements on nanoparticles prior to biological impact assessment.
Roebben, G.; Ramirez-Garcia, S.; Hackley, V. A., Roesslein, M.; Klaessig, F.; Kestens, V.; Lynch, I.; Garner, C. M.; Rawle, A.; Elder, A.; Colvin, V. L.; Kreyling, W.; Krug, H. F.; Lewicka, Z. A.; McNeil, S. E.; Nel, A.; Patri, A. K.; Wick, P.; Wiesner, M.; Xia, T.; Oberdorster, G.; Dawson, K. A.
Journal of Nanoparticle Research, 2011, 13(7), 2675-2687.

Characterization of nanoparticles intended for drug delivery.
Methods in Molecular Biology: Humana Press; 2011, Scott E. McNeil, editor.
ISBN: 978-1-60327-197-4

Fullerenol Cytotoxicity in Kidney Cells is Associated with Cytoskeleton Disruption, Autophagy Induction, and Mitochondrial Dysfunction
Johnson-Lyles, D. N.; Peifley, K.; Lockett, S.; Neun, B. W.; Hansen, M.; Clogston, J.; Stern, S. T.; McNeil, S. E.
Toxicology and Applied Pharmacology, 2010, 248(3), 249-258.
PMID: 20713077

Translational considerations for cancer nanomedicine.
Stern, S. T.; Hall, J. B.; Yu, L. L.; Wood, L. J.; Paciotti, G. F.; Tamarkin, L.; Long, S. E.; McNeil, S. E.
Journal of Controlled Release. 2010, 146(2), 164-174.
PMID: 20385183

Biological Assessment of Triazine Dendrimers as Candidate Platforms for Nanomedicine: Toxicological Profiles, Solution Behavior, Biodistribution, and Drug Release and Efficacy in a PEGylated, Paclitaxel Construct.
Lo, S. T.; Stern, S.; Clogston, J. D.; Zheng, J.; Adiseshaiah, P. P.; Dobrovolskaia, M.; Lim, J.; Patri, A.; Sun, X.; Simanek, E. E.
Molecular Pharmaceutics, 2010, 7(4), 993-1006.
PMID: 20481608

A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.
Ahn, R.; Chen, F.; Stern, S. T.; Clogston, J. D.; Patri, A. K.; Raja, M. R.; Swindell, E. P.; Parimi, V.; Cryns, V. L.; O’Halloran, T.
Clinical Cancer Research, 2010, 16(14), 3607-3617.
PMID: 20519360

Ambiguities in applying traditional Limulus Amoebocyte Lysate tests to quantify endotoxin in nanoparticle formulations.
Dobrovolskaia, M. A.; Neun, B. W.; Clogston, J. D.; Ding, H.; Ljubimova, J.;
McNeil, S. E.
Nanomedicine (Lond.), 2010, 5(4), 555-562.
PMID: 20528451

Lack of significant dermal penetration of titanium dioxide (TiO2) from sunscreen formulations containing nano- and sub-micron-size TiO2 particles.
Sadrieh, N.; Wokovich, A. M.; Gopee, N. V.; Zheng, J.; Haines, D.; Parmiter, D.; Siitonen, P. H.; Cozart, C. R.; Patri, A.; McNeil, S. E.; Howard, P. C.; Doub, W. H.; Buhse, L. F.
Toxicological Sciences, 2010, 115(1), 156-166.
PMID: 20156837

Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of (198)AuNP-GA nanoconstruct in prostate tumor-bearing mice.
Chanda, N.; Kan, P.; Watkinson, L. D.; Shukla, R.; Zambre, A.; Carmack, T. L.; Engelbrecht, H.; Lever, J. R.; Katti, K.; Fent, G. M.; Casteel, S. W.; Smith, C. J.; Miller, W. H.; Jurisson, S.; Boote, E.; Robertson, J. D.; Cutler, C.; Dobrovolskaia, M.; Kannan, R.; Katti, K. V.
Nanomedicine:Nanotechnology, Biology, and Medicine, 2010, 6(2), 201-209. 
PMID: 19914401

Minireview: Nanoparticles and the immune system.
Zolnik, B. S.; Gonzalez-Fernandez, A.; Sadrieh, N.; Dobrovolskaia, M. A.
Endocrinology. 2010, 151(2), 458-465. 
PMID: 20016026

Nanomaterial standards for efficacy and toxicity assessment.
Adiseshaiah, P.; Hall, J. B.; McNeil, S. E.
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2010, 2(1), 99-112.  PMID: 20049834

Quantitative characterization of quantum dot-labeled lambda phage for Escherichia coli detection.
Yim, P. B.; Clarke, M. L.; McKinstry, M.; De Paoli Lacerda, S. H.; Pease, L. F.; Dobrovolskaia, M. A.; Kang, H.; Read, T. D.; Sozhamannan, S.; Hwang, J.
Biotechnology and Bioengineering. 2009, 104(6), 1059-1067. 
PMID: 19634184

Energy dispersive X-ray analysis of titanium dioxide nanoparticle distribution after intravenous and subcutaneous injection in mice.
Patri, A.; Umbreit, T.; Zheng, J.; Nagashima, K.; Goering, P.; Francke-Carroll, S.; Gordon, E.; Weaver, J.; Miller, T.; Sadrieh, N.; McNeil, S. E.; Stratmeyer, M.
Journal of Applied Toxicology. 2009, 29(8), 662-672. 
PMID: 19626582

Immunological properties of engineered nanomaterials.
Dobrovolskaia, M.; McNeil, S. E.
Nanoscience and Technology: A Collection of Reviews from Nature Journals: World Scientific Publishing Company 2009, Peter Rodgers, editor. 
ISBN: 978-981-4282-68-0

Evaluation of nanoparticle immunotoxicity.
Dobrovolskaia, M. A.; Germolec, D. R.; Weaver, J. L.
Nature Nanotechnology. 2009, 4(7), 411-414. 
PMID: 19581891

Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.
Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E.
Nanomedicine: Nanotechnology, Medicine, and Biology. 2009, 5(2), 106-117. 
PMID: 19071065

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
Aggarwal, P.; Hall, J. B.; McLeland, C. B.; Dobrovolskaia, M. A.; McNeil, S. E.
Advanced Drug Delivery Reviews. 2009, 61(6), 428-437. 
PMID: 19376175

Nanoparticle therapeutics: a personal perspective.
McNeil, S. E.
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2009, 1(3), 264-271.  PMID: 20049796

In Review: Nanomaterial Safety.
McNeil, S. E.
Bulletin of the Atomic Scientists. 2009, 65(1), 56-61.

HER2-Specific affibody-conjugated thermosensitive liposomes (affisomes) for improved delivery of anticancer agents.
Puri, A.; Kramer-Marek, G.; Campbell-Massa, R.; Yavlovich, A.; Tele, S. C.; Lee, S.-B.; Clogston, J. D.; Patri, A. K.; Blumenthal, R.; Capala, J.
Journal of Liposome Research. 2008, 18(4), 293-307. 
PMID: 18937120

Detoxification of gold nanorods by treatment with polystyrenesulfonate.
Leonov, A. P.; Zheng, J. W.; Clogston, J. D.; Stern, S. T.; Patri, A. K.; Wei, A.
ACS Nano. 2008, 2(12), 2481-2488. 
PMID: 19206282

Role for nanomaterial-autophagy interaction in neurodegenerative disease.
Stern, S. T.; Johnson, D. N.
Autophagy. 2008, 4(8), 1097-1100. 
PMID: 18927490

Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials?
Stern, S. T.; Zolnik, B. S.; McLeland, C. B.; Clogston, J.; Zheng, J.; McNeil, S. E.
Toxicological Sciences. 2008, 106(1), 140-152. 
PMID: 18632727

Method for analysis of nanoparticle hemolytic properties in vitro.
Dobrovolskaia, M. A.; Clogston, J. D.; Neun, B. W.; Hall, J. B.; Patri, A. K.; McNeil, S. E.
Nano Letters. 2008, 8(8), 2180-2187. 
PMID: 18605701

Rapid distribution of liposomal short-chain ceramide in vitro and in vivo.
Zolnik, B. S.; Stern, S. T.; Kaiser, J. M.; Heakal, Y.; Clogston, J. D.; Kester, M.; McNeil, S. E.
Drug Metabolism and Disposition. 2008, 36(8), 1709-1715. 
PMID: 18490436

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.
Dobrovolskaia, M. A.; Aggarwal, P.; Hall, J. B.; McNeil, S. E.
Molecular Pharmaceutics. 2008, 5(4), 487-495. 
PMID: 18510338

Biodistribution of nanomedicines.
Simanek, E.; Patri, A.
Molecular Pharmaceutics. 2008, 5(4), 473. 
PMID: 18672948

Adverse effects of fulerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-I membrane expression and apoptosis in vitro.
Gelderman, M. P.; Simakova, O.; Clogston, J.; Patri, A.; Siddiqui, S. F.; Vostal, A. C.; Simak, J.
International Journal of  Nanomedicine. 2008, 3(1), 59-68. 
PMID: 18488416

Nanotechnology safety concerns revisited.
Stern, S. T.; McNeil, S. E.
Toxicological Sciences. 2008, 101(1), 4-21. 
PMID: 17602205

Characterization of nanoparticles for therapeutics.
Hall, J. B.; Dobrovolskaia, M. A.; Patri, A. K.; McNeil, S. E.
Nanomedicine. 2007, 2(6), 789-803. 
PMID: 18095846

Immunological properties of engineered nanomaterials.
Dobrovolskaia, M. A.; McNeil, S. E.
Nature Nanotechnology. 2007, 2(8), 469-478. 
PMID: 18654343

Medical opportunities of nanotechnology.
McNeil, S. E.
ISO Focus. April 2007, Nanotechnologies issue, p. 16-18.

Analysis of fullerene-based nanomaterial in serum matrix by CE.
Chan, K. C.; Patri, A. K.; Veenstra, T. D.; McNeil, S. E.; Issaq, H. J.
Electrophoresis. 2007, 28(10), 1518-1524. 
PMID: 17447247

Nanocrystal-based biomimetic system for quantitative flow cytometry.
Yim, P.; Dobrovolskaia, M.; Kang, H.; Clarke, M.; Patri, A.; Hwang, J.
Advanced Biomedical and Clinical Diagnostic Systems V, Proc of SPIE, Volume 6430, 2007; San Jose, CA: SPIE; 2007. p. 64301T1-64301T9, Vo-Dinh, T.; Grundfest, W. S.; Benaron, D. A.; Cohn, G. E.; Raghavachari, R., editors.
ISBN: 9780819465436

Preclinical characterization of engineered nanoparticles intended for cancer therapeutics.
Patri, A.; Dobrovolskaia, M.; Stern, S. T.; McNeil, S. E.
Nanotechnology for Cancer Therapy. New York: CRC Press; 2006. p. 105-138, Mansoor Amiji, editor.
ISBN: 978-0849371943

Nanotechnology for the biologist.
McNeil, S. E.
Journal of Leukocyte Biology. 2005, 78(3), 585-594. 
PMID: 15923216

 

 

 
       
       
National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthFirstGov.govNCI - Alliance for Nanotechnology in Cancer
National Cancer Institute U.S. National Institutes of Health www.cancer.gov Nanotechnology Characterization Lab